NASDAQ:CLSN - Nasdaq - US15117N6022 - Common Stock - Currency: USD
TTM (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 500.00K | 500.00K | 500.00K | 500.00K | 500.00K | |||
Operating Expenses | 22.87M | 21.51M | 18.99M | 21.07M | 21.57M | |||
Research and Development | 11.78M | 10.62M | 11.34M | 13.07M | 11.87M | |||
Selling, General, and Administrative Expenses | 11.10M | 10.89M | 7.64M | 8.00M | 9.70M | |||
Operating Income | -22.37M | -21.01M | -18.49M | -20.57M | -21.07M | |||
Interest Income/Expense | -4.88M | -558.88K | -1.17M | -1.29M | -390.00K | |||
Other Income/Expense | 1.70M | 1.62M | -1.30M | 3.19M | 3.66M | |||
Non Recurring Items | N/A | -2.21M | -2.37M | 0.00 | -4.51M | |||
Income Before Taxes | -27.53M | -22.15M | -23.33M | -18.67M | -22.30M | |||
Income Tax | N/A | -1.38M | -1.85M | -1.82M | -10.42M | |||
Net Income | -26.15M | -20.77M | -21.48M | -16.85M | -11.88M | |||
EBITDA | -21.71M | -20.30M | -17.75M | -19.85M | -20.71M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -4.35 | -3.83 | -0.67 | -0.77 | -0.68 | |||
Non GAAP EPS | -7.21 | -5.51 | -10.05 | -2.14 | N/A | |||
Statistics | ||||||||
Profit Margin | -5229.82% | -4153.85% | -4296.00% | -3370.00% | -2376.00% | |||
Operating Profit Margin | -4474.54% | -4201.44% | -3698.00% | -4114.00% | -4214.00% |
All data in USD